Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.

[1]  L. Cannon-Albright,et al.  Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer , 2017, JAMA oncology.

[2]  D. Tindall,et al.  HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. , 2016, The Lancet. Oncology.

[3]  David F Jarrard,et al.  Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. , 2015, The New England journal of medicine.

[4]  K. Nastiuk,et al.  Variant allele of HSD3B1 increases progression to castration‐resistant prostate cancer , 2015, The Prostate.

[5]  Yongwei Yu,et al.  miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.

[6]  P. Nelson,et al.  A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer , 2013, Cell.

[7]  Rui Li,et al.  Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer , 2011, Proceedings of the National Academy of Sciences.

[8]  R. Auchus,et al.  3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer. , 2010, Endocrinology.

[9]  K. Knudsen,et al.  Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer , 2010, Trends in Endocrinology & Metabolism.

[10]  S. Shariat,et al.  Perspectives on prostate cancer biomarkers. , 2008, European urology.

[11]  J. Carpten,et al.  Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. , 2002, Cancer research.

[12]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.

[13]  J. Varley,et al.  Cloning, expression, and physical mapping of the 3beta-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human. , 1999, Genomics.

[14]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[15]  S. Balk,et al.  Mechanisms mediating androgen receptor reactivation after castration. , 2009, Urologic oncology.